2Blanchard A, Yaneg A, Dybrig K, et al. Evaluaetion of intraspecies genetic variation within the 16 SrRNA gene of mycoplasma and detection by polywrase chain reaction [J]. J Clin Microbiol , 1993, 31: 1358-1361.
3Limb DI.Mycoplasma of the human genital tract[J].J Med Lab Sci,1989,45:146.
4Waites KB, Crabb DM, Duffy LB. Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT -492and other antimicrobial agents against human mycoplasmas and ureaplasmas [ J ]. Antimicrob Agents Chemother, 2003,47 ( 12 ): 3973 -3975.
5Waites KB,Crabb DM, Bing X,et al. In vitro susceptibilities to and bactericidal activities of garenoxacin ( BMS-284756 ) and other antimicrobial agents against human mycoplasmas and ureaplasmas [J]. Antimicrob Agents Chemother,2003,47 (1) :161 -165.
6Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma hominis, M.pneumoniae, and Ureaplasma urealyticum to GAR - 936, dalfopristin,dirithromycin, evemimicin, gatifloxacin, linezolid, moxifloxacin,quinupristin- dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones [J]. Antimicrob Agents Chemother, 2001,45 (9) :2604 - 2608.
7Vazquez F,Carreno F,Perez AF,et al. Comparision of 3 culture methods for genital mycoplasma[J]. Enferm Infect Microbial Clin, 1995,13(8) :460.
8Taylor-robinson D, Rzins S. The Mycoplasmas [ M ]. New York: Academic, Press, 1985.27.
9Karo N, Kato H, Otsubo K. et al. In vitro aetivity of minoeyeline against Chlamydia trachomatis clinical isolates and clinical efficacy of minocvcline to C. trachomatis associated nongonocoeeal urethritis. Jpn J Antibiot, 1988, 41: 1550-1556.
10Rumpianesi F, Morandotti G. Sperning R.et al. In vitro aetivity of azithromyein against Chlamydia trachomatis. Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin. roxithromycin and minoeyeline J Chemother.1993, 5: 155-158.
